↓ Skip to main content

Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1

Overview of attention for article published in Frontiers in Pharmacology, February 2024
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1
Published in
Frontiers in Pharmacology, February 2024
DOI 10.3389/fphar.2024.1345645
Pubmed ID
Authors

Putri Cahaya Situmorang, Syafruddin Ilyas, Rony Abdi Syahputra, Reka Mustika Sari, Alexander Patera Nugraha, Alek Ibrahim

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 13%
Student > Bachelor 1 6%
Lecturer 1 6%
Student > Doctoral Student 1 6%
Student > Master 1 6%
Other 0 0%
Unknown 10 63%
Readers by discipline Count As %
Unspecified 2 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Agricultural and Biological Sciences 1 6%
Unknown 11 69%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2024.
All research outputs
#16,797,272
of 25,480,126 outputs
Outputs from Frontiers in Pharmacology
#6,405
of 19,841 outputs
Outputs of similar age
#96,946
of 202,084 outputs
Outputs of similar age from Frontiers in Pharmacology
#50
of 494 outputs
Altmetric has tracked 25,480,126 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,841 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,084 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 494 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.